Literature DB >> 23174196

Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults.

Maria Kakoulidou1, Hanna Ingelman-Sundberg, Elin Johansson, Alberto Cagigi, Salah Eldin Farouk, Anna Nilsson, Kari Johansen.   

Abstract

The persistence of antigen-specific memory B-cells (MBCs) in children and young adults long time after vaccination against measles, mumps and rubella (MMR) is not known. Here we have looked at the Swedish immunization program and examined children 1-10 years after the first MMR dose in early childhood, as well as young adults 7-18 years after the second dose of MMR. We show that Ab titers and MBCs against measles and rubella have different kinetics, indicating that the MBC pool and the corresponding Ab titers are regulated independently. These data fit well with other findings that continuous IgG secretion comes from long-lived plasma cells and not MBCs. We also demonstrate that individuals with low post-vaccination Ab titers might have an adequate MBC response. It remains to be shown if memory B-cells provide the same protection as specific antibodies, but our data is a valuable complement to the incomplete knowledge about correlates of protection after vaccination.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23174196     DOI: 10.1016/j.vaccine.2012.11.031

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Waning and aging of cellular immunity to Bordetella pertussis.

Authors:  Inonge van Twillert; Wanda G H Han; Cécile A C M van Els
Journal:  Pathog Dis       Date:  2015-09-13       Impact factor: 3.166

2.  The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study.

Authors:  Giuseppe La Torre; Rosella Saulle; Brigid Unim; Angela Meggiolaro; Angelo Barbato; Alice Mannocci; Antonietta Spadea
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

Review 3.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

4.  Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Krista M Goergen; Diane E Grill; Min-Hsin Chen; Lijuan Hao; Joseph Icenogle; Gregory A Poland
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

Review 5.  Variability in Humoral Immunity to Measles Vaccine: New Developments.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Jennifer A Whitaker; Gregory A Poland
Journal:  Trends Mol Med       Date:  2015-11-18       Impact factor: 11.951

Review 6.  Rubella.

Authors:  Nathaniel Lambert; Peter Strebel; Walter Orenstein; Joseph Icenogle; Gregory A Poland
Journal:  Lancet       Date:  2015-01-08       Impact factor: 79.321

7.  Persistence of rubella and mumps antibodies, following changes in the recommended age for the second dose of MMR vaccine in Portugal.

Authors:  G Gonçalves; J Frade; M S J Nascimento; J R Mesquita; C Nunes
Journal:  Epidemiol Infect       Date:  2016-08-04       Impact factor: 4.434

8.  Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood.

Authors:  Mohammed Ata Ur Rasheed; Carole J Hickman; Marcia McGrew; Sun Bae Sowers; Sara Mercader; Amy Hopkins; Vickie Grimes; Tianwei Yu; Jens Wrammert; Mark J Mulligan; William J Bellini; Paul A Rota; Walter A Orenstein; Rafi Ahmed; Srilatha Edupuganti
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-03       Impact factor: 12.779

Review 9.  Current perspectives in assessing humoral immunity after measles vaccination.

Authors:  Iana H Haralambieva; Richard B Kennedy; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2018-12-26       Impact factor: 5.683

10.  Differential B-cell memory around the 11-month booster in children vaccinated with a 10- or 13-valent pneumococcal conjugate vaccine.

Authors:  Els van Westen; Alienke J Wijmenga-Monsuur; Harry H van Dijken; Jacqueline A M van Gaans-van den Brink; Betsy Kuipers; Mirjam J Knol; Guy A M Berbers; Elisabeth A M Sanders; Nynke Y Rots; Cécile A C M van Els
Journal:  Clin Infect Dis       Date:  2015-04-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.